SCHEMBL24517329

SCHEMBL24517329

CS(C)(C)C#Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.51
▸ MAPT P10636 3/20 0.48
▸ GAA P10253 3/20 0.48
▸ TP53 P04637 2/20 0.48
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ SLC2A1 P11166 5/20 0.45
▸ KDM4E B2RXH2 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ NR1I2 O75469 1/20 0.43
▸ ABCB11 O95342 1/20 0.43
▸ ALB P02768 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ TSPO P30536 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ OPRM1 P35372 1/20 0.43
▸ DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24517328 0.90 ALDH1A1 (0.41) ALDH1A1MAPTGAATP53MEN1
SCHEMBL24517305 0.84 KDM4E (0.53) ALDH1A1MAPTGAAKMT2ASLC2A1
SCHEMBL24517327 0.82 ALDH1A1 (0.52) ALDH1A1MAPTGAATP53MEN1
SCHEMBL24517331 0.78 CYP11B1 (0.41) ALDH1A1MAPTSLC2A1KDM4EHTT
SCHEMBL24517332 0.76 GAA (0.37) ALDH1A1MAPTGAATP53SLC2A1
SCHEMBL24517322 0.75 GAA (0.47) MAPTGAA
SCHEMBL24516932 0.75 AKT1 (0.38) ALDH1A1GAAKDM4ETSPOKCNH2
SCHEMBL24517334 0.74 KDM4E (0.39) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL22614974 0.72 SLC2A3 (0.44) ALDH1A1MAPTGAATP53MEN1
SCHEMBL24517687 0.71 NPC1 (0.54) ALDH1A1MAPTGAATP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185822-A1 SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185822-A1 SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR NR1I2, NR1H2, NR1H4 ALDH1A1 435/4885MAPT 3921/4885GAA 2097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback